
This visual helps illustrate the nuances of each type of bagging in specialty pharmacy and what it may mean for your health system.
Key considerations in understanding 340B program results and benefits.
Date
July 13, 2021
Read time: less than 1 minute
A lack of transparency across the pharmacy marketplace stems from a number of different factors. Ultimately, it impacts the patient experience and can create confusion.
Heightened transparency across the broader system could help support health systems’ ability to generate savings and revenue to support extending care to the uninsured and underinsured, which is key to extending pharmacy and patient care services.
Andrew Wilson, vice president, 340B Solutions for McKesson, shares three key considerations in understanding 340B program results and benefits. Read more from Drug Topics.
This visual helps illustrate the nuances of each type of bagging in specialty pharmacy and what it may mean for your health system.
As strategic partners, our Specialty Pharmacy Enablement experts can help drive improvements across the board.
In a unique, retreat-style setting, health systems leaders had close conversations around best practices, wins, struggles, and solutions.
Discover three key takeaways from a recent C-suite roundtable discussing the benefits and challenges of central fill for health systems.
Industry event highlights how connection, creativity, and a fresh perspective are shaping the future of health system innovation.
An exclusive introduction to our newest services and solutions designed to help forward-thinking health systems modernize their specialty and infusion strategies.
Drug shortages have decreased, but supply chain complexity requires ongoing innovation and resilience to maintain drug availability.
Integrated health system specialty pharmacies improve medication access, enhance treatment plan adherence, and support better outcomes.